Presentation of Biovitrum's Interim Report October - December and Full Year Report for 2009

(Thomson Reuters ONE) - In conjunction with the announcement of the Biovitrum AB (publ) Interim Reportfor the fourth quarter and Full Year Report 2009, Swedish Orphan Biovitrum wouldlike to invite you to a media and investor meeting in Stockholm on Thursday,February 18.The report will be presented by Swedish Orphan Biovitrum´s CEO Martin Nicklassonand CFO G? Arvidson. The presentation will be held in English and webcasted. Time:           Thursday, February 18, 2010 at 3 p.m. (CET) Venue:        Bolinderska rummet, Grand H?, Stockholm                     Coffee will be servedThe report is expected to be published around 8.30 a.m. (CET) the same day.Registration: Please register for participation to Mikael Nilimaa onmikael.nilimaa(at)zoomvision.se or bytelephone +46 702 699 322.Webcast:The presentation will be webcasted, February 18 at 3 p.m.(CET):www.biovitrum.com .Telephone dial in: UK: + 44 208 817 9301, Swe:+46 (0) 850 520 270, US: +1718 354 1226___________________________________________________________________The presentation material will be published on our web site after the meeting aswill the archived web cast, please go to: www.biovitrum.com.Welcome!Erik Kinnman, EVP Investor RelationsPhone: +46 8 697 21 50,erik.kinnman(at)biovitrum.comAbout Swedish Orphan BiovitrumOn January 14, 2010, Biovitrum AB (publ) completed the acquisition of SwedishOrphan International Holding AB and created Swedish Orphan Biovitrum - a leadingcompany focused on treatment of rare diseases.Swedish Orphan Biovitrum is a Swedish based specialty pharmaceutical companywith an international market presence. The company is focused on providing anddeveloping orphan and niche specialist pharmaceuticals to patients with highmedical needs. The portfolio consists of about 60 marketed products and anemerging late stage clinical development pipe-line within rare diseases. SwedishOrphan Biovitrum has pro-forma revenues 2009e of about 2 BSEK and approximately500 employees. The head office is located in Sweden and the share (STO: BVT) islisted on NASDAQ OMX Stockholm. For more information please visitwww.biovitrum.com .[HUG#1384089] Invitation in PDF format: http://hugin.info/134557/R/1384089/342854.pdf

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 12.02.2010 - 15:01 Uhr
Sprache: Deutsch
News-ID 12456
Anzahl Zeichen: 0

contact information:
Town:

Stockholm

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 178 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Presentation of Biovitrum's Interim Report October - December and Full Year Report for 2009"
steht unter der journalistisch-redaktionellen Verantwortung von

Biovitrum (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Biovitrum AB (publ) completes the acquisition of Swedish Orphan International Ho ...

Biovitrum AB?s (publ) rights issue fully subscribed ...

Biovitrum AB (publ) makes public a prospectus supplement ...

Alle Meldungen von Biovitrum